Skip to main content
Erschienen in: Journal of Neuro-Oncology 3/2016

30.01.2016 | Clinical Study

Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery

verfasst von: Amir Zolal, Tareq A. Juratli, Jennifer Linn, Dino Podlesek, Kerim Hakan Sitoci Ficici, Hagen H. Kitzler, Gabriele Schackert, Stephan B. Sobottka, Bernhard Rieger, Dietmar Krex

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Objective To determine the value of apparent diffusion coefficient (ADC) histogram parameters for the prediction of individual survival in patients undergoing surgery for recurrent glioblastoma (GBM) in a retrospective cohort study. Methods Thirty-one patients who underwent surgery for first recurrence of a known GBM between 2008 and 2012 were included. The following parameters were collected: age, sex, enhancing tumor size, mean ADC, median ADC, ADC skewness, ADC kurtosis and fifth percentile of the ADC histogram, initial progression free survival (PFS), extent of second resection and further adjuvant treatment. The association of these parameters with survival and PFS after second surgery was analyzed using log-rank test and Cox regression. Results Using log-rank test, ADC histogram skewness of the enhancing tumor was significantly associated with both survival (p = 0.001) and PFS after second surgery (p = 0.005). Further parameters associated with prolonged survival after second surgery were: gross total resection at second surgery (p = 0.026), tumor size (0.040) and third surgery (p = 0.003). In the multivariate Cox analysis, ADC histogram skewness was shown to be an independent prognostic factor for survival after second surgery. Conclusion ADC histogram skewness of the enhancing lesion, enhancing lesion size, third surgery, as well as gross total resection have been shown to be associated with survival following the second surgery. ADC histogram skewness was an independent prognostic factor for survival in the multivariate analysis.
Literatur
1.
Zurück zum Zitat Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996CrossRefPubMed Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996CrossRefPubMed
2.
Zurück zum Zitat Wong ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, Levin VA, Yung WK (1999) Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 17:2572–2578PubMed Wong ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, Levin VA, Yung WK (1999) Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 17:2572–2578PubMed
3.
Zurück zum Zitat Barker FG, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB (1998) Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42:709–720CrossRefPubMed Barker FG, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB (1998) Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42:709–720CrossRefPubMed
4.
Zurück zum Zitat Barbagallo GMV, Jenkinson MD, Brodbelt AR (2008) “Recurrent” glioblastoma multiforme, when should we reoperate? Br J Neurosurg 22:452–455CrossRefPubMed Barbagallo GMV, Jenkinson MD, Brodbelt AR (2008) “Recurrent” glioblastoma multiforme, when should we reoperate? Br J Neurosurg 22:452–455CrossRefPubMed
5.
Zurück zum Zitat Pope WB, Lai A, Mehta R et al (2011) apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. Am J Neuroradiol 32:882–889CrossRefPubMed Pope WB, Lai A, Mehta R et al (2011) apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. Am J Neuroradiol 32:882–889CrossRefPubMed
6.
Zurück zum Zitat Ryu YJ, Choi SH, Park SJ, Yun TJ, Kim J-H, Sohn C-H (2014) Glioma: application of whole-tumor texture analysis of diffusion-weighted imaging for the evaluation of tumor heterogeneity. PLoS ONE 9:e108335CrossRefPubMedPubMedCentral Ryu YJ, Choi SH, Park SJ, Yun TJ, Kim J-H, Sohn C-H (2014) Glioma: application of whole-tumor texture analysis of diffusion-weighted imaging for the evaluation of tumor heterogeneity. PLoS ONE 9:e108335CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Wen Q, Jalilian L, Lupo JM, Molinaro AM, Chang SM, Clarke J, Prados M, Nelson SJ (2014) Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab. J Neurooncol 121:331–339CrossRefPubMedPubMedCentral Wen Q, Jalilian L, Lupo JM, Molinaro AM, Chang SM, Clarke J, Prados M, Nelson SJ (2014) Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab. J Neurooncol 121:331–339CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Elson A, Paulson E, Bovi J, Siker M, Schultz C, Laviolette PS (2015) Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme. J Neurooncol 123:179–188CrossRefPubMed Elson A, Paulson E, Bovi J, Siker M, Schultz C, Laviolette PS (2015) Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme. J Neurooncol 123:179–188CrossRefPubMed
9.
Zurück zum Zitat Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage 17:825–841CrossRefPubMed Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage 17:825–841CrossRefPubMed
10.
11.
Zurück zum Zitat Avants BB, Epstein CL, Grossman M, Gee JC (2008) Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med Image Anal 12:26–41CrossRefPubMedPubMedCentral Avants BB, Epstein CL, Grossman M, Gee JC (2008) Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med Image Anal 12:26–41CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Zhang Y, Brady M, Smith S (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20:45–57CrossRefPubMed Zhang Y, Brady M, Smith S (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20:45–57CrossRefPubMed
13.
Zurück zum Zitat Quick J, Gessler F, Dützmann S, Hattingen E, Harter PN, Weise LM, Franz K, Seifert V, Senft C (2014) Benefit of tumor resection for recurrent glioblastoma. J Neurooncol 117:365–372CrossRefPubMed Quick J, Gessler F, Dützmann S, Hattingen E, Harter PN, Weise LM, Franz K, Seifert V, Senft C (2014) Benefit of tumor resection for recurrent glioblastoma. J Neurooncol 117:365–372CrossRefPubMed
14.
Zurück zum Zitat Chaichana KL, Zadnik P, Weingart JD, Olivi A, Gallia GL, Blakeley J, Lim M, Brem H, Quiñones-Hinojosa A (2013) Multiple resections for patients with glioblastoma: prolonging survival. J Neurosurg 118:812–820CrossRefPubMedPubMedCentral Chaichana KL, Zadnik P, Weingart JD, Olivi A, Gallia GL, Blakeley J, Lim M, Brem H, Quiñones-Hinojosa A (2013) Multiple resections for patients with glioblastoma: prolonging survival. J Neurosurg 118:812–820CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Gupta RK, Cloughesy TF, Sinha U, Garakian J, Lazareff J, Rubino G, Rubino L, Becker DP, Vinters HV, Alger JR (2000) Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 50:215–226CrossRefPubMed Gupta RK, Cloughesy TF, Sinha U, Garakian J, Lazareff J, Rubino G, Rubino L, Becker DP, Vinters HV, Alger JR (2000) Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 50:215–226CrossRefPubMed
16.
Zurück zum Zitat Castillo M, Smith JK, Kwock L, Wilber K (2001) Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. Am J Neuroradiol 22:60–64PubMed Castillo M, Smith JK, Kwock L, Wilber K (2001) Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. Am J Neuroradiol 22:60–64PubMed
17.
Zurück zum Zitat Pope WB, Kim HJ, Huo J et al (2009) Recurrent glioblastoma multiforme: adc histogram analysis predicts response to bevacizumab treatment. Radiology 252:182–189CrossRefPubMed Pope WB, Kim HJ, Huo J et al (2009) Recurrent glioblastoma multiforme: adc histogram analysis predicts response to bevacizumab treatment. Radiology 252:182–189CrossRefPubMed
18.
Zurück zum Zitat Asao C, Korogi Y, Kitajima M, Hirai T, Baba Y, Makino K, Kochi M, Morishita S, Yamashita Y (2005) Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. Am J Neuroradiol 26:1455–1460PubMed Asao C, Korogi Y, Kitajima M, Hirai T, Baba Y, Makino K, Kochi M, Morishita S, Yamashita Y (2005) Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. Am J Neuroradiol 26:1455–1460PubMed
19.
Zurück zum Zitat Hu LS, Eschbacher JM, Heiserman JE et al (2012) Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival. Neuro-Oncol 14:919–930CrossRefPubMedPubMedCentral Hu LS, Eschbacher JM, Heiserman JE et al (2012) Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival. Neuro-Oncol 14:919–930CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Nowosielski M, Recheis W, Goebel G, Güler Ö, Tinkhauser G, Kostron H, Schocke M, Gotwald T, Stockhammer G, Hutterer M (2011) ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma. Neuroradiology 53:291–302CrossRefPubMedPubMedCentral Nowosielski M, Recheis W, Goebel G, Güler Ö, Tinkhauser G, Kostron H, Schocke M, Gotwald T, Stockhammer G, Hutterer M (2011) ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma. Neuroradiology 53:291–302CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Ellingson BM, Kim HJ, Woodworth DC, Pope WB, Cloughesy JN, Harris RJ, Lai A, Nghiemphu PL, Cloughesy TF (2014) Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial. Radiology 271:200–210CrossRefPubMedPubMedCentral Ellingson BM, Kim HJ, Woodworth DC, Pope WB, Cloughesy JN, Harris RJ, Lai A, Nghiemphu PL, Cloughesy TF (2014) Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial. Radiology 271:200–210CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Grech-Sollars M, Hales PW, Miyazaki K et al (2015) Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain. NMR Biomed 28:468–485CrossRefPubMedPubMedCentral Grech-Sollars M, Hales PW, Miyazaki K et al (2015) Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain. NMR Biomed 28:468–485CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Doane DP, Seward LE (2011) Measuring skewness: a forgotten statistic. J Stat Educ 19:1–18 Doane DP, Seward LE (2011) Measuring skewness: a forgotten statistic. J Stat Educ 19:1–18
Metadaten
Titel
Enhancing tumor apparent diffusion coefficient histogram skewness stratifies the postoperative survival in recurrent glioblastoma multiforme patients undergoing salvage surgery
verfasst von
Amir Zolal
Tareq A. Juratli
Jennifer Linn
Dino Podlesek
Kerim Hakan Sitoci Ficici
Hagen H. Kitzler
Gabriele Schackert
Stephan B. Sobottka
Bernhard Rieger
Dietmar Krex
Publikationsdatum
30.01.2016
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 3/2016
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-016-2063-7

Weitere Artikel der Ausgabe 3/2016

Journal of Neuro-Oncology 3/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.